Amgen, Inc. (AMGN)
377.35
-5.12
(-1.34%)
USD |
NASDAQ |
Sep 11, 16:00
377.81
+0.46
(+0.12%)
After-Hours: 20:00
Amgen Price to Book Value : 17.45 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 17.45 |
| September 10, 2026 | 17.69 |
| September 09, 2026 | 18.10 |
| September 08, 2026 | 18.19 |
| September 04, 2026 | 20.22 |
| September 03, 2026 | 20.54 |
| September 02, 2026 | 20.48 |
| September 01, 2026 | 20.26 |
| August 31, 2026 | 19.88 |
| August 28, 2026 | 20.00 |
| August 27, 2026 | 20.21 |
| August 26, 2026 | 20.37 |
| August 25, 2026 | 20.45 |
| August 24, 2026 | 20.53 |
| August 21, 2026 | 20.32 |
| August 20, 2026 | 20.06 |
| August 19, 2026 | 20.46 |
| August 18, 2026 | 19.67 |
| August 17, 2026 | 19.40 |
| August 14, 2026 | 19.20 |
| August 13, 2026 | 19.33 |
| August 12, 2026 | 19.25 |
| August 11, 2026 | 19.16 |
| August 10, 2026 | 19.30 |
| August 07, 2026 | 19.01 |
| Date | Value |
|---|---|
| August 06, 2026 | 18.73 |
| August 05, 2026 | 18.86 |
| August 04, 2026 | 18.04 |
| August 03, 2026 | 17.52 |
| July 31, 2026 | 17.81 |
| July 30, 2026 | 17.93 |
| July 29, 2026 | 17.93 |
| July 28, 2026 | 18.18 |
| July 27, 2026 | 17.40 |
| July 24, 2026 | 17.39 |
| July 23, 2026 | 17.18 |
| July 22, 2026 | 16.93 |
| July 21, 2026 | 16.94 |
| July 20, 2026 | 16.84 |
| July 17, 2026 | 16.94 |
| July 16, 2026 | 17.19 |
| July 15, 2026 | 16.57 |
| July 14, 2026 | 16.43 |
| July 13, 2026 | 16.67 |
| July 10, 2026 | 16.81 |
| July 09, 2026 | 16.82 |
| July 08, 2026 | 17.02 |
| July 07, 2026 | 17.03 |
| July 06, 2026 | 16.95 |
| July 02, 2026 | 17.31 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.08 |
| Regeneron Pharmaceuticals, Inc. | 2.548 |
| AbbVie, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 6.449 |
| Biogen, Inc. | 1.702 |
Price to Book Value Related Metrics
| PE Ratio | 23.44 |
| PS Ratio | 5.366 |
| PEG Ratio | 0.7394 |
| Price to Free Cash Flow | 20.15 |
| Price | 377.35 |
| Earnings Yield | 4.27% |
| Market Cap | 204.00B |
| PEGY Ratio | 0.6827 |
| Operating PE Ratio | 16.11 |
| Normalized PE Ratio | 21.39 |